In This Article:
It's been a sad week for thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2), who've watched their investment drop 12% to €8.73 in the week since the company reported its second-quarter result. Revenues were €216m, with thyssenkrupp nucera KGaA reporting some 2.0% below analyst expectations. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
Following the recent earnings report, the consensus from eleven analysts covering thyssenkrupp nucera KGaA is for revenues of €895.7m in 2025. This implies a discernible 7.6% decline in revenue compared to the last 12 months. Statutory earnings per share are expected to nosedive 62% to €0.072 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of €890.3m and earnings per share (EPS) of €0.072 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
Check out our latest analysis for thyssenkrupp nucera KGaA
It will come as no surprise then, to learn that the consensus price target is largely unchanged at €12.30. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on thyssenkrupp nucera KGaA, with the most bullish analyst valuing it at €17.00 and the most bearish at €8.50 per share. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 15% by the end of 2025. This indicates a significant reduction from annual growth of 33% over the last year. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.0% per year. It's pretty clear that thyssenkrupp nucera KGaA's revenues are expected to perform substantially worse than the wider industry.